User profiles for B. KAHALEH
Bashar Kahalehunuvwesity of Toledo Verified email at utoledo.edu Cited by 10562 |
Cardiovascular disease in autoimmune rheumatic diseases
…, S Curran, CS Goodyear, KA Hestad, B Kahaleh… - Autoimmunity …, 2013 - Elsevier
… In the subintimal aortic layers, the FHBS has so far has identified eg, T-cells, B-cells and
cytokines involved in their regulation [B-cell activating factor (BAFF), and A proliferation-…
cytokines involved in their regulation [B-cell activating factor (BAFF), and A proliferation-…
International consensus criteria for the diagnosis of Raynaud's phenomenon
…, LK Hummers, C Duong, B Kahaleh… - Journal of …, 2014 - Elsevier
Vasoconstriction accompanied by changes in skin color is a normal physiologic response to
cold. The distinction between this normal physiology and Raynaud's phenomenon (RP) has …
cold. The distinction between this normal physiology and Raynaud's phenomenon (RP) has …
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
Objective The 1980 American College of Rheumatology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
Vascular disease in scleroderma: mechanisms of vascular injury
B Kahaleh - Rheumatic Disease Clinics of North America, 2008 - Elsevier
… Swelling of the intima and intimal proliferation with mononuclear cell infiltration are seen
in the early stages and consist of infiltrating macrophages and activated T and B cells with a …
in the early stages and consist of infiltrating macrophages and activated T and B cells with a …
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
Objective. The 1980 American College of Rheuma-tology (ACR) classification criteria for
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
systemic sclerosis (SSc) lack sensitivity for early SSc and limited cutaneous SSc. The present …
The effect of dynamic versus isometric resistance training on pain and functioning among adults with osteoarthritis of the knee
… Topp R, Woolley S, Hornyak J III, Khuder S, Kahaleh B. The effect of dynamic versus isometric
resistance training on pain and functioning among adults with osteoarthritis of the knee. …
resistance training on pain and functioning among adults with osteoarthritis of the knee. …
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts
… B, Normal fibroblasts were transfected with the antisense construct pcDNA4/TO/FLI1AS
and immunoblotted (upper panel), and expression levels of type I collagen were quantified (…
and immunoblotted (upper panel), and expression levels of type I collagen were quantified (…
[HTML][HTML] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
… Bashar Kahaleh … B Use of nintedanib and tocilizumab. *Data from the 2022 supplementary
Delphi. † … 4B, Additional file 1: Table S2). The panelists’ consensus was that the decision to …
Delphi. † … 4B, Additional file 1: Table S2). The panelists’ consensus was that the decision to …
[HTML][HTML] Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative
…, D Collier, ME Csuka, S Jimenez, B Kahaleh… - Arthritis and …, 2013 - ncbi.nlm.nih.gov
… The system was tested by: a) determining specificity and sensitivity in SSc cases and
controls with scleroderma-like disorders; b) validating against the combined view of a group of …
controls with scleroderma-like disorders; b) validating against the combined view of a group of …
MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial
…, B Kahaleh, ME Csuka, B Gruber… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Raynaud's phenomenon (RP) affects 3–9% of the general population and >90%
of patients with systemic sclerosis. Nitrates are often prescribed for the treatment of RP, but …
of patients with systemic sclerosis. Nitrates are often prescribed for the treatment of RP, but …